Matches in Nanopublications for { ?s ?p "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP587776.RAlLvdL2MhAgBQvZ7x_K9sp1KyDBg-pDUrbpxufpmWNhg130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587776.RAlLvdL2MhAgBQvZ7x_K9sp1KyDBg-pDUrbpxufpmWNhg130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP371852.RAFi0b6lsZo59I3s8nYHjXoNfYFv4IhqIHsAb-CGH7A0c130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371852.RAFi0b6lsZo59I3s8nYHjXoNfYFv4IhqIHsAb-CGH7A0c130_provenance.
- assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP535591.RAOUK4GpdkGpQQiWgTLx7PJKWZCzsLtNsYulJ7lfrEkhc130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535591.RAOUK4GpdkGpQQiWgTLx7PJKWZCzsLtNsYulJ7lfrEkhc130_provenance.
- NP535391.RA83zzjXbw91iN4AUQz78SLvs-lsNVg1noHD6RlyPMxIA130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535391.RA83zzjXbw91iN4AUQz78SLvs-lsNVg1noHD6RlyPMxIA130_provenance.
- NP703903.RANPum-pcCDEF7YIJA2FiiWRNjjVDh528qlAp8DjbbFbI130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703903.RANPum-pcCDEF7YIJA2FiiWRNjjVDh528qlAp8DjbbFbI130_provenance.
- NP703901.RA3TiKh-VS-x1qHZ_AIlmY7UrwqURJlDyfijJzwTmaa6k130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703901.RA3TiKh-VS-x1qHZ_AIlmY7UrwqURJlDyfijJzwTmaa6k130_provenance.